Liposome-Mediated Delivery Improves the Efficacy of Lisosan G against Retinopathy in Diabetic Mice

• Published in: Cells (Basel, Switzerland) Switzerland), 2023-10, Vol.12 (20), p.2448
• Main Authors: Amato, Rosario, Melecchi, Alberto, Pucci, Laura, Canovai, Alessio, Marracci, Silvia, Cammalleri, Maurizio, Dal Monte, Massimo, Caddeo, Carla, Casini, Giovanni
• Format: Article
• Language: English
• Subjects: Animals; Anti-inflammatory agents; Apoptosis; Bioavailability; Care and treatment; Diabetes; Diabetes mellitus; Diabetic retinopathy; Dietary supplements; Drinking water; electroretinography; Encapsulation; Flavonoids; Functional foods & nutraceuticals; Glaucoma; Health aspects; Inflammation; Liposomes; nanocarriers; nutraceutical; Oxidants; Oxidative stress; Retina; Retinopathy; Streptozocin; Vascular endothelial growth factor
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12202448

Nutraceuticals are natural substances whose anti-oxidant and anti-inflammatory properties may be used to treat retinal pathologies. Their efficacy is limited by poor bioavailability, which could be improved using nanocarriers. Lisosan G (LG), a fermented powder from whole grains, protects the retina from diabetic retinopathy (DR)-induced damage. For this study, we tested whether the encapsulation of LG in liposomes (LipoLG) may increase its protective effects. Diabetes was induced in mice via streptozotocin administration, and the mice were allowed to freely drink water or a water dispersion of two different doses of LG or of LipoLG. Electroretinographic recordings after 6 weeks showed that only the highest dose of LG could partially protect the retina from diabetes-induced functional deficits, while both doses of LipoLG were effective. An evaluation of molecular markers of oxidative stress, inflammation, apoptosis, vascular endothelial growth factor, and the blood–retinal barrier confirmed that the highest dose of LG only partially protected the retina from DR-induced changes, while virtually complete prevention was obtained with either dose of LipoLG. These data indicate that the efficacy of LG in contrasting DR is greatly enhanced by its encapsulation in liposomes and may lay the ground for new dietary supplements with improved therapeutic effects against DR.